The clinical significance of MIB-1 labeling index in pituitary adenomas

Pituitary

Volumn 13, Issue 4, 2010, Pages 337-344

  Chacko, Geeta ^a   Chacko, Ari G ^a   Kovacs, Kalman ^b   Scheithauer, Bernd W ^c   Mani, Sunithi ^a   Muliyil, J P ^a   Seshadri, M S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

MIB 1 labeling index; Pituitary adenomas

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CANCER INVASION; CANCER LOCALIZATION; CAVERNOUS SINUS; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYDROCEPHALUS; HYPOPHYSIS ADENOMA; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MIB 1 LABELING INDEX; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; SEX DIFFERENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; SEX FACTORS; YOUNG ADULT;

EID: 78049294580     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-010-0242-7     Document Type: Article

References (47)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) Pathology and genetics. Tumors of endocrine organs In: World Health Organization Classification of Tumors Lyon: IARC Press
2. S Melmed 2009 Acromegaly pathogenesis and treatment J Clin Invest 119 3189 3202 1:CAS:528:DC%2BD1MXhtlOitrjO 10.1172/JCI39375 19884662
3. SL Asa S Ezzat 2009 The pathogenesis of pituitary tumors Annu Rev Pathol 4 97 126 1:CAS:528:DC%2BD1MXis1aiu74%3D 10.1146/annurev.pathol.4.110807.092259 19400692
4. WE Farrell 2006 Pituitary tumours: findings from whole genome analyses Endocr Relat Cancer 13 707 716 1:CAS:528:DC%2BD28Xhtlequr%2FF 10.1677/erc.1.01131 16954426 (Pubitemid 44763253)
5. SD Pack LX Qin E Pak, et al. 2005 Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization Genes Chromosomes Cancer 43 72 82 1:CAS:528:DC%2BD2MXjt1Kqsbc%3D 10.1002/gcc.20162 15704128 (Pubitemid 40490356)
6. J Szymas K Schluens W Liebert I Petersen 2002 Genomic instability in pituitary adenomas Pituitary 5 211 219 1:CAS:528:DC%2BD3sXmsFejtbg%3D 10.1023/A:1025313214951 14558668 (Pubitemid 37184441)
7. AP Heaney GA Horwitz Z Wang R Singson S Melmed 1999 Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis Nat Med 5 1317 1321 1:CAS:528: DyaK1MXnt1ymsLo%3D 10.1038/15275 10546001 (Pubitemid 29535612)
8. CJ McCabe K Boelaert LA Tannahill AP Heaney AL Stratford JS Khaira S Hussain MC Sheppard JA Franklyn NJ Gittoes 2002 Vascular endothelial growth factor, its receptor kdr/flk-1, and pituitary tumor transforming gene in pituitary tumors J Clin Endocrinol Metab 87 4238 4244 1:CAS:528: DC%2BD38XntFOls7c%3D 10.1210/jc.2002-020309 12213878
9. I De Martino R Visone A Wierinckx D Palmieri A Ferraro P Cappabianca G Chiappetta F Forzati G Lombardi A Colao J Trouillas M Fedele A Fusco 2009 HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas Cancer Res 69 1844 1850 10.1158/0008-5472.CAN-08-4133 19223528
10. G Vlotides T Eigler S Melmed 2007 Pituitary tumor-transforming gene: physiology and implications for tumorigenesis Endocr Rev 28 165 186 1:CAS:528:DC%2BD2sXkvFentrw%3D 10.1210/er.2006-0042 17325339 (Pubitemid 46984833)
11. X Zhang H Sun DC Danila SR Johnson Y Zhou B Swearingen A Klibanski 2002 Loss of expression of gadd45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis J Clin Endocrinol Metab 87 1262 1267 1:CAS:528:DC%2BD38XitlWns78%3D 10.1210/jc.87.3.1262 11889197 (Pubitemid 36121097)
12. WE Farrell 2005 Epigenetic mechanisms of tumorigenesis Horm Metab Res 37 361 368 1:CAS:528:DC%2BD2MXmslGjs70%3D 10.1055/s-2005-870153 16001328 (Pubitemid 41008770)
13. S Chatterjee PL May G Forster D Spiller RV Jeffreys 1993 Prediction of recurrence in pituitary tumours: a flow cytometric study using in vivo bromodeoxyuridine Br J Neurosurg 7 165 169 1:STN:280:DyaK3s3mtl2quw%3D%3D 10.3109/02688699309103473 8494618
14. PL Fitzgibbons AJ Appley RR Turner PC Bishop JW Parker RE Breeze MH Weiss ML Apuzzo 1988 Flow cytometric analysis of pituitary tumors correlation of nuclear antigen p105 and DNA content with clinical behavior Cancer 62 1556 1560 1:STN:280:DyaL1M%2Fgt1Kitg%3D%3D 10.1002/1097-0142(19881015)62:8<1556::AID- CNCR2820620816>3.0.CO;2-O 3048631
15. R Gandour-Edwards SB Kapadia IP Janecka AJ Martinez L Barnes 1995 Biologic markers of invasive pituitary adenomas involving the sphenoid sinus Mod Pathol 8 160 164 1:STN:280:DyaK2M3ps1aksg%3D%3D 7777477
16. DW Hsu F Hakim BM Biller S de la Monte NT Zervas A Klibanski ET Hedley-Whyte 1993 Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence J Neurosurg 78 753 761 1:STN:280:DyaK3s3isV2ksQ%3D%3D 10.3171/jns.1993.78.5.0753 8096873
17. K Kitz E Knosp WT Koos A Korn 1991 Proliferation in pituitary adenomas: measurement by MAb KI 67 Acta Neurochir Suppl (Wien) 53 60 64 1:STN:280:DyaK383gs1agsg%3D%3D
18. E Knosp K Kitz A Perneczky 1989 Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67 Neurosurgery 25 927 930 1:STN:280:DyaK3c%2FpvVansQ%3D%3D 10.1097/00006123-198912000-00012 2601824
19. AM Landolt T Shibata P Kleihues 1987 Growth rate of human pituitary adenomas J Neurosurg 67 803 806 1:STN:280:DyaL1c%2FmtFGqtQ%3D%3D 10.3171/jns.1987.67.6.0803 3681419
20. R Lath G Chacko MJ Chandy 2001 Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody Neurol India 49 144 147 1:STN:280:DC%2BD3Mzpt12nsQ%3D%3D 11447433
21. L Mastronardi A Guiducci F Puzzilli 2001 Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas BMC Cancer 1 12 1:STN:280:DC%2BD38votFymuw%3D%3D 10.1186/1471-2407-1-12 11570981 (Pubitemid 38846507)
22. S Schreiber W Saeger DK Ludecke 1999 Proliferation markers in different types of clinically non-secreting pituitary adenomas Pituitary 1 213 220 1:STN:280:DC%2BD3M%2FlsF2ntA%3D%3D 10.1023/A:1009933820856 11081200
23. K Thapar K Kovacs BW Scheithauer L Stefaneanu E Horvath PJ Pernicone D Murray ER Laws Jr 1996 Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody Neurosurgery 38 99 106 1:STN:280:DyaK28zlsVShsw%3D%3D 10.1097/00006123-199601000-00024 8747957 (Pubitemid 26002389)
24. KI Paek SH Kim SH Song SW Choi HS Koh JY Youm Y Kim 2005 Clinical significance of Ki-67 labeling index in pituitary macroadenoma J Korean Med Sci 20 489 494 10.3346/jkms.2005.20.3.489 15953875
25. CB Pizarro MC Oliveira LB Coutinho NP Ferreira 2004 Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody Braz J Med Biol Res 37 235 243 1:CAS:528:DC%2BD2cXisFCqurY%3D 10.1590/S0100- 879X2004000200011 14762579
26. JP Cottier C Destrieux L Brunereau P Bertrand L Moreau M Jan D Herbreteau 2000 Cavernous sinus invasion by pituitary adenoma: MR imaging Radiology 215 463 469 1:STN:280:DC%2BD3c3ls12qsA%3D%3D 10796926
27. A Devaprasath G Chacko 2003 Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas Neurol India 51 336 340 1:STN:280:DC%2BD3srntV2gtA%3D%3D 14652433
28. K Yonezawa N Tamaki T Kokunai 1997 Clinical features and growth fractions of pituitary adenomas Surg Neurol 48 494 500 1:STN:280:DyaK1c%2FhsVWrsw%3D%3D 10.1016/S0090-3019(97)00102-X 9352815 (Pubitemid 27463625)
29. Y Tanaka K Hongo T Tada K Sakai Y Kakizawa S Kobayashi 2003 Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time patient age and MIB-1 index J Neurosurg 98 359 365 10.3171/jns.2003.98.2.0359 12593623
30. M Losa 1999 Pituitary tumors in the elderly Eur J Endocrinol 140 378 380 1:CAS:528:DyaK1MXjslegurw%3D 10.1530/eje.0.1400378 10229900 (Pubitemid 29254001)
31. M Losa A Franzin F Mangili MR Terreni R Barzaghi F Veglia P Mortini M Giovanelli 2000 Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results Neurosurgery 47 1313 1318 1:STN:280:DC%2BD3M7gtl2guw%3D%3D 10.1097/00006123- 200012000-00009 11126902
32. E Delgrange J Trouillas D Maiter J Donckier J Tourniaire 1997 Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study J Clin Endocrinol Metab 82 2102 2107 1:CAS:528:DyaK2sXksVCnsro%3D 10.1210/jc.82.7.2102 9215279 (Pubitemid 27287568)
33. RD Calle-Rodrigue C Giannini BW Scheithauer RV Lloyd PC Wollan KT Kovacs L Stefaneanu AB Ebright CF Abboud DH Davis 1998 Prolactinomas in male and female patients: a comparative clinicopathologic study Mayo Clin Proc 73 1046 1052 1:STN:280:DyaK1M%2FjsFeqtQ%3D%3D 10.4065/73.11.1046 9818037
34. BW Scheithauer TA Gaffey RV Lloyd TJ Sebo KT Kovacs E Horvath O Yapicier WF Young Jr FB Meyer T Kuroki DL Riehle ER Laws Jr 2006 Pathobiology of pituitary adenomas and carcinomas Neurosurgery 59 341 353 10.1227/01.NEU. 0000223437.51435.6E 16883174 (Pubitemid 44325877)
35. L Mastronardi A Guiducci C Spera F Puzzilli F Liberati A Ruggeri A Peciarolo 2000 Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody Tumori 86 229 232 1:STN:280:DC%2BD3czpvFarsw%3D%3D 10939604
36. M Eda N Saeki N Fujimoto K Sunami 2002 Demonstration of the optic pathway in large pituitary adenoma on heavily t2 weighted mr images Br J Neurosurg 16 21 29 1:STN:280:DC%2BD387psVSmsw%3D%3D 10.1080/02688690120114192 11926461 (Pubitemid 34246182)
37. T Iuchi N Saeki K Osato A Yamaura 2000 Proliferation vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas Acta Neurochir (Wien) 142 1345 1351 1:STN:280:DC%2BD3M7nvFyrug%3D%3D 10.1007/s007010070003 (Pubitemid 32204507)
38. K Thapar BW Scheithauer K Kovacs PJ Pernicone ER Laws Jr 1996 p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions Neurosurgery 38 765 770 1:STN:280: DyaK283kslyhuw%3D%3D 10.1097/00006123-199604000-00027 8692397
39. J Honegger C Prettin F Feuerhake M Petrick J Schulte-Monting M Reincke 2003 Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness J Neurosurg 99 674 679 10.3171/jns.2003.99.4.0674 14567602
40. H Kawamoto T Uozumi K Kawamoto K Arita T Yano T Hirohata 1995 Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas Acta Neurochir (Wien) 136 37 43 1:STN:280:DyaK28zlt1yisg%3D%3D 10.1007/BF01411433
41. U Bannur G Chacko MJ Chandy 1998 AgNOR count as an index of invasion in pituitary adenoma Br J Neurosurg 12 582 584 10.1080/02688699844493
42. A Goel T Nadkarni D Muzumdar K Desai U Phalke P Sharma 2004 Giant pituitary tumors: a study based on surgical treatment of 118 cases Surg Neurol 61 436 445 10.1016/j.surneu.2003.08.036 15120215 (Pubitemid 38543084)
43. SM Ekramullah Y Saitoh N Arita T Ohnishi T Hayakawa 1996 The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas Acta Neurochir (Wien) 138 1449 1455 1:STN:280:DyaK2s7ot1eisQ%3D%3D 10.1007/BF01411125 (Pubitemid 27010696)
44. W Saeger 2005 Pituitary tumors: prognostic indicators Endocrine 28 57 66 1:CAS:528:DC%2BD2MXht1yks73K 10.1385/ENDO:28:1:057 16311411
45. de Aguiar PH, Aires R, Laws ER, Isolan GR, Logullo A, Patil C, Katznelson L (2010) Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review. Neurol Res (EPub ahead of print)
46. G Widhalm S Wolfsberger M Preusser I Fischer A Woehrer J Wunderer JA Hainfellner E Knosp 2009 Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression J Neurosurg 111 563 571 10.3171/2008.4.17517 18991501
47. F Salehi A Agur BW Scheithauer, et al. 2009 Ki-67 in pituitary neoplasms: a review-part I Neurosurgery 65 429 437 10.1227/01.NEU.0000349930.66434.82 19687686 discussion 437